Related references
Note: Only part of the references are listed.Cause-Specific Cardiovascular Risk Associated with Nonsteroidal Anti-Inflammatory Drugs among Myocardial Infarction Patients - A Nationwide Study
Anne-Marie Schjerning Olsen et al.
PLOS ONE (2013)
Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis
Atsushi Goto et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Comparative Effectiveness of Sulfonylurea and Metformin Monotherapy on Cardiovascular Events in Type 2 Diabetes Mellitus A Cohort Study
Christianne L. Roumie et al.
ANNALS OF INTERNAL MEDICINE (2012)
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
S. E. Inzucchi et al.
DIABETOLOGIA (2012)
The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients
Sandra K. Thygesen et al.
BMC MEDICAL RESEARCH METHODOLOGY (2011)
Comparable long-term mortality risk associated with individual sulfonylureas in diabetes patients with heart failure
Charlotte Andersson et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Resolving drug effects from class effects among drugs for type 2 diabetes mellitus: more support for cardiovascular outcome assessments
M. Odette Gore et al.
EUROPEAN HEART JOURNAL (2011)
Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study
Tina Ken Schramm et al.
EUROPEAN HEART JOURNAL (2011)
Severe Hypoglycemia and Risks of Vascular Events and Death.
Sophia Zoungas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study
Denise E. Bonds et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Glibenclamide-related excess in total and cardiovascular mortality risks: Data from large Ukrainian observational cohort study
Mykola Khalangot et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2009)
Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
D. M. Nathan et al.
DIABETOLOGIA (2009)
Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database
Ioanna Tzoulaki et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial
Soren S. Lund et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
No differences in mortality between users of pancreatic-specific and non-pancreatic-specific sulphonylureas: a cohort analysis
Josie M. M. Evans et al.
DIABETES OBESITY & METABOLISM (2008)
Paget's disease of the mandible
Mayank B. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Intensive glycemic control in the ACCORD and ADVANCE trials
Robert G. Dluhy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Impact of oral antihyperglycemic therapy on all-cause mortality among patients with diabetes in the Veterans Health Administration
Kristijan H. Kahler et al.
DIABETES CARE (2007)
A systematic review and meta-analysis of hypoglycemia and cardiovascular event - A comparison of glyburide with other secretagogues and with insulin
Azim S. Gangji et al.
DIABETES CARE (2007)
Myocardial protection from either ischaemic preconditioning or nicorandil is not blocked by gliclazide
HL Maddock et al.
CARDIOVASCULAR DRUGS AND THERAPY (2004)
Differential selectivity of insulin secretagogues - Mechanisms, clinical implications, and drug interactions
FM Gribble et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2003)
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
P Gaede et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Initial management of glycemia in type 2 diabetes mellitus
DM Nathan
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Sulfonylurea inadequacy - Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57)
A Wright et al.
DIABETES CARE (2002)
Share Paper
